Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Classification & Labelling & PBT assessment

PBT assessment

Currently viewing:

Administrative data

PBT assessment: overall result

Reference
Name:
Desmedipham
Type of composition:
legal entity composition of the substance
State / form:
solid: particulate/powder
Reference substance:
Desmedipham
PBT status:
the substance is not PBT / vPvB
Justification:

The test substance is not considered PBT or vPvB based on the following information:


Persistence: Based on a DT50 value of  < 1 day in an aerobic mineralisation study, desmedipham is not considered to be persistent, however an aniline metabolite has a DT50 value of 81.1 days. Thus, desmedipham must be considered as vP. In a water/sediment study the observed mineralisation DT50 value is >365 days, and in addition the soil mineralisation DT50 value is >200 days, therefore desmedipham must be considered to be P and vP in accordance with the criteria of REACH Annex XIII.


 


Bioaccumulation: Based on the BCF value 333.9 L/kg in whole fish, the substance is considered not B or vB.


 


Toxicity: The substance is classified as Reproductivity toxicity category 2 (H361d) according to CLP. Thus, it meets the T-criterion.


In conclusion, desmedipham is not PBT/vPvB.